Here we show that conditions of tumor microenvironment and TMDF act to increase lysosomal degradation of antigens and attenuate their cross-presentation in DCs in a manner dependent on the upregulation of activating transcription factor-3 (ATF3) and downregulation of cholesterol 25-hydroxylase (CH25H). This evidence concerns the gene ATF3 and neoplasm.